Hao Tang

机构：Stanford Health Care, Stanford University · ORCID：0000-0001-9409-5220

发表论文 90 篇 · 总被引 2041 次 · h-index 26

代表论文

• Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors (2024 · EBioMedicine · 被引 45)
• Comparative analysis of chloroplast and mitochondrial genomes of sweet potato provides evidence of gene transfer (2024 · Scientific Reports · 被引 15)
• Knowledge, attitude and practice on fall risk factors and prevention among rural older community-dwellers in Vietnam (2023 · PLoS ONE · 被引 15)
• Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB–D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915 (2025 · Journal for ImmunoTherapy of Cancer · 被引 11)
• Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer—CDK4/6 Inhibitors: ASCO Rapid Guideline Update Clinical Insights (2024 · JCO Oncology Practice · 被引 10)
• Chaigui Bitong decoction inhibits rheumatoid arthritis fibroblast-like synoviocyte injury through regulating the ferroptosis signaling pathway via Nrf2/HO-1/GPX4 axis (2025 · Current Pharmaceutical Analysis · 被引 5)